ArticleCase reports in hematology2025

Treatment of Relapsed/Refractory t(11;14) Multiple Myeloma and High-Risk Myelodysplastic Syndrome With Venetoclax.

Allison O Taylor et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.